Clinical Trial Update: Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial update evaluating adjuvant dynamic marker-adjusted personalized therapy for risk assessment and therapy response prediction in early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: West German Study Group | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED